Mutations or antibodies that disrupt FH function are correlated with conditions that dysregulate complement activity, such as atypical hemolytic uremic syndrome (aHUS) (8–10), C3 glomerulopathy (C3G) (11–14), and age-related macular degeneration (AMD) (15–18). This evidence concerns the gene FH and complement 3 glomerulopathy.